Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Enteromedics (ETRM)

Enteromedics
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ETRM
DateTimeSourceHeadlineSymbolCompany
23/10/201721:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
23/10/201713:30PR Newswire (US)EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS)NASDAQ:ETRMEnteromedics
17/10/201721:15Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ETRMEnteromedics
16/10/201713:00PR Newswire (US)EnteroMedics Announces Presentations at ObesityWeek 2017NASDAQ:ETRMEnteromedics
12/10/201723:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETRMEnteromedics
12/10/201723:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETRMEnteromedics
12/10/201723:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETRMEnteromedics
12/10/201721:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ETRMEnteromedics
12/10/201721:46PR Newswire (US)EnteroMedics Announces New Employee Inducement Option GrantsNASDAQ:ETRMEnteromedics
06/10/201714:04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ETRMEnteromedics
03/10/201713:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
03/10/201713:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ETRMEnteromedics
03/10/201713:30PR Newswire (US)EnteroMedics Announces Acquisition Of ReShape MedicalNASDAQ:ETRMEnteromedics
12/09/201713:30PR Newswire (US)EnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare ConferenceNASDAQ:ETRMEnteromedics
05/09/201721:15PR Newswire (US)EnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc TherapyNASDAQ:ETRMEnteromedics
28/08/201721:05PR Newswire (US)Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-EffectiveNASDAQ:ETRMEnteromedics
24/08/201722:02Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:ETRMEnteromedics
21/08/201714:00PR Newswire (US)EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in MarylandNASDAQ:ETRMEnteromedics
16/08/201722:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
16/08/201714:00PR Newswire (US)EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual ConferenceNASDAQ:ETRMEnteromedics
15/08/201721:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETRMEnteromedics
11/08/201721:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETRMEnteromedics
11/08/201713:20PR Newswire (US)EnteroMedics Announces Pricing of $20 Million Underwritten Public OfferingNASDAQ:ETRMEnteromedics
11/08/201713:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
10/08/201721:34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETRMEnteromedics
10/08/201721:34PR Newswire (US)EnteroMedics Announces Proposed Underwritten Public OfferingNASDAQ:ETRMEnteromedics
08/08/201721:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ETRMEnteromedics
08/08/201713:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
08/08/201712:00PR Newswire (US)EnteroMedics Announces Second Quarter 2017 Financial ResultsNASDAQ:ETRMEnteromedics
02/08/201712:00PR Newswire (US)EnteroMedics To Discuss Business Strategy And Financial Results For The Second Quarter Of 2017NASDAQ:ETRMEnteromedics
 Showing the most relevant articles for your search:NASDAQ:ETRM